site stats
Welcome, register | help | log in

Novel Prostate Cancer Treatment, Pioneered at Sunnybrook Research Institute (SRI)

flickr_2397656696.jpg
© memekode
A promising novel therapy for the treatment of prostate cancer is being pioneered in development and commercialization by scientists at Sunnybrook Research Institute (SRI) in Toronto.

The said treatment is called magnetic resonance imaging (MRI)-guided transurethral ultrasound - a treatment that utilizes heat from focused ultrasound to treat cancer in the prostate gland precisely while sparing the delicate noncancerous tissues around the prostate essential for healthy urinary, bowel and sexual function.

Sunnybrook researchers Dr. Michael Bronskill and Dr. Rajiv Chopra have licensed their innovation and formed Profound Medical Inc., which will develop the technology for clinical use.

Unlike surgical removal of the prostate, the treatment is minimally invasive and could be performed without a lengthy hospital stay. In preclinical studies, treatment takes less than 30 minutes. The therapy, on which clinicians at Sunnybrook will conduct preliminary testing in preparation for a clinical trial, could help limit the number of men living with the common, debilitating and often permanent side effects of surgery and radiation treatments currently used.

More of these invasive therapies are being performed now because improved awareness among younger men has converged with better clinical detection tools.

This treatment hopefully will provide faster and more precise treatment with fewer side effects compared to existing clinical alternatives.

Find more details from Sunny Brook Research Instistitute (SRI).

See full article
.

Related Entries:

New Virus Found In Prostate Tumors Suggests Prostate Cancer May Be An Infectious Disease - 27 February 2006

Healthmark Mutimedia's Your Decision Notebook®: Innovative CD-ROM to Help Men Participate in Making - 19 April 2006

Novel Protein, Potential Drug Target for Treatment-Resistant Prostate Cancer - 31 December 2007

Seven Biomarkers for Prostate Cancer Recurrence or Progression Identified - 23 June 2008

Contents of this feed are a property of Creative Weblogging Limited and are protected by copyright laws. Violations will be prosecuted. Please email us if you'd like to use this feed for non-commercial activities at feeds - at - creative-weblogging.com.

Tagged as: 

Post new comment

[?]
The content of this field is kept private and will not be shown publicly.
Captcha Image: you will need to recognize the text in it.
[?]
Please type in the letters/numbers that are shown in the image above.



Copyright © 2005-2011, Aquave Group Inc, Privacy Policy

User login